- Patent Title: Crystalline forms of neurotrophin mimetic compounds and their salts
-
Application No.: US15264425Application Date: 2016-09-13
-
Publication No.: US09884833B2Publication Date: 2018-02-06
- Inventor: Rajgopal Munigeti , Frank M. Longo
- Applicant: Pharmatrophix, Inc.
- Applicant Address: US CA Menlo Park
- Assignee: PharmatrophiX, Inc.
- Current Assignee: PharmatrophiX, Inc.
- Current Assignee Address: US CA Menlo Park
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: A61K31/435
- IPC: A61K31/435 ; C07D295/13
Abstract:
The present invention includes crystalline forms of 2-amino-3-methyl-N-(2-morpholinoethyl)-pentanamide disulfate and crystalline forms of 2-amino-3-methyl-N-(2-morpholinoethyl)-pentanamide monosulfate. Furthermore, the present invention provides compositions comprising the crystalline forms and therapeutic use of the crystalline forms. In one embodiment, the crystalline compound is (2S,3S)-2-amino-3-methyl-N-(2-morpholinoethyl)-pentanamide.
Public/Granted literature
- US20170158653A1 CRYSTALLINE FORMS OF NEUROTROPHIN MIMETIC COMPOUNDS AND THEIR SALTS Public/Granted day:2017-06-08
Information query
